SARS-CoV-2 Viral Entry and Renin-Angiotensin System Disruption

Cellular Tropism: Why the Lungs?

Viruses are limited by their "tropism," or the specific cell types they can infect. SARS-CoV-2 has a high affinity for cells expressing ACE2 receptors. In the respiratory system, these receptors are highly expressed on Type II pneumocytes, the cells responsible for surfactant production in the alveoli. This explains why the lungs are a primary site of injury during infection.

Exam Tip: Remember that ACE2 is not just a "doorway" for the virus; it is a functional enzyme in the body. The virus doesn't just use the receptor; it disrupts it.

Disruption of the Renin-Angiotensin System (RAS)

One of the most dangerous aspects of SARS-CoV-2 is its impact on the Renin-angiotensin system (RAS), a hormonal pathway that regulates blood pressure and fluid balance.

In a healthy body, the RAS maintains a delicate balance between two enzymes:

• ACE1 (Angiotensin-converting enzyme): Converts Angiotensin I into Angiotensin II.
• ACE2: Acts as a counter-regulator by breaking down Angiotensin II, thereby preventing excessive vasoconstriction and inflammation.

The ACE1/ACE2 Imbalance

When SARS-CoV-2 infects a cell, it binds to the ACE2 receptor to gain entry. This process effectively reduces the number of active ACE2 receptors available on the cell surface.

This leads to a critical physiological imbalance:

1. Decreased ACE2 activity: The body can no longer efficiently clear Angiotensin II.
2. Increased Angiotensin II levels: Because ACE1 continues to function, Angiotensin II accumulates.

Angiotensin II is a powerful vasoconstrictor that raises blood pressure and stimulates thirst. However, in the context of a viral infection, excessive Angiotensin II acts as a pro-inflammatory signal.

Inflammation and Lung Injury

The resulting imbalance in the RAS triggers a cascade of inflammation and lung injury. The accumulation of Angiotensin II promotes the release of inflammatory cytokines, which can lead to widespread tissue damage. In the lungs, this manifests as severe inflammation of the alveolar tissues, potentially leading to respiratory failure. This systemic disruption highlights why SARS-CoV-2 is much more than a simple respiratory infection; it is a disruptor of fundamental homeostatic mechanisms.